120 related articles for article (PubMed ID: 29350457)
1. Improved outcome at end of treatment in the collaborative Wilms tumour Africa project.
Israels T; Paintsil V; Nyirenda D; Kouya F; Mbah Afungchwi G; Hesseling P; Tump C; Kaspers G; Burns L; Singh Arora R; Chagaluka G; Nana P; Renner L; Molyneux E
Pediatr Blood Cancer; 2018 May; 65(5):e26945. PubMed ID: 29350457
[TBL] [Abstract][Full Text] [Related]
2. Improvement of overall survival in the Collaborative Wilms Tumour Africa Project.
Chagaluka G; Paintsil V; Renner L; Weijers J; Chitsike I; Borgstein E; Kamiza S; Afungchwi GM; Kouya F; Hesseling P; Molyneux E; Israels T
Pediatr Blood Cancer; 2020 Sep; 67(9):e28383. PubMed ID: 32391983
[TBL] [Abstract][Full Text] [Related]
3. The Collaborative Wilms Tumour Africa Project; baseline evaluation of Wilms tumour treatment and outcome in eight institutes in sub-Saharan Africa.
Paintsil V; David H; Kambugu J; Renner L; Kouya F; Eden T; Hesseling P; Molyneux E; Israels T
Eur J Cancer; 2015 Jan; 51(1):84-91. PubMed ID: 25465189
[TBL] [Abstract][Full Text] [Related]
4. Survival of children with a Wilms tumor in Blantyre, Malawi.
Israels T; Pidini D; Borgstein E; Bailey S; Tump C; Chagaluka G; Kamiza S; Molyneux E
Pediatr Hematol Oncol; 2018 Apr; 35(3):196-202. PubMed ID: 30239249
[TBL] [Abstract][Full Text] [Related]
5. Outcome at the end of treatment of patients with common and curable childhood cancer types in Blantyre, Malawi.
Chakumatha E; Weijers J; Banda K; Bailey S; Molyneux E; Chagaluka G; Israels T
Pediatr Blood Cancer; 2020 Jul; 67(7):e28322. PubMed ID: 32391955
[TBL] [Abstract][Full Text] [Related]
6. The results of treatment of children with metastatic Wilms tumours (WT) in an African setting: do liver metastases have a negative impact on survival?
Aronson DC; Maharaj A; Sheik-Gafoor MH; Hadley GP
Pediatr Blood Cancer; 2012 Aug; 59(2):391-4. PubMed ID: 22315136
[TBL] [Abstract][Full Text] [Related]
7. Wilms tumor in Africa: A systematic review of management challenges and outcome in two decades (2000-2019).
Ekenze SO; Okafor OC; Obasi AA; Okafor DC; Nnabugwu II
Pediatr Blood Cancer; 2020 Nov; 67(11):e28695. PubMed ID: 32909662
[TBL] [Abstract][Full Text] [Related]
8. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors.
Aoba T; Urushihara N; Fukumoto K; Furuta S; Fukuzawa H; Mitsunaga M; Watanabe K; Yamoto M; Miyake H; Koyama M; Iwabuchi H; Koike J; Tatsunami S; Wakisaka M; Kitagawa H
J Pediatr Surg; 2012 Dec; 47(12):2210-5. PubMed ID: 23217878
[TBL] [Abstract][Full Text] [Related]
9. A 20-year prospective study of Wilms tumor and other kidney tumors: a report from Hong Kong pediatric hematology and oncology study group.
Chan CC; To KF; Yuen HL; Shing Chiang AK; Ling SC; Li CH; Cheuk DK; Li CK; Shing MM
J Pediatr Hematol Oncol; 2014 Aug; 36(6):445-50. PubMed ID: 25050908
[TBL] [Abstract][Full Text] [Related]
10. [Wilms tumors. Diagnosis and therapy].
Graf N; Reinhard H
Urologe A; 2003 Mar; 42(3):W391-407; quiz W408-9. PubMed ID: 12723542
[No Abstract] [Full Text] [Related]
11. [The assessment of nephroblastoma therapy results using the SIOP 92-01 protocol].
Madziara W; Bohosiewicz J
Wiad Lek; 1998; 51 Suppl 3():106-9. PubMed ID: 9814117
[TBL] [Abstract][Full Text] [Related]
12. Wilms' tumour: a 30 year experience at Wellington Hospital.
Delahunt B; Nacey JN; Lewis ME; Pringle KC; Russell GL
N Z Med J; 1990 Jun; 103(891):267-9. PubMed ID: 2162507
[TBL] [Abstract][Full Text] [Related]
13. Outcome of renal tumors registered in Japan Wilms Tumor Study-2 (JWiTS-2): A report from the Japan Children's Cancer Group (JCCG).
Koshinaga T; Takimoto T; Oue T; Okita H; Tanaka Y; Nozaki M; Tsuchiya K; Inoue E; Haruta M; Kaneko Y; Fukuzawa M
Pediatr Blood Cancer; 2018 Jul; 65(7):e27056. PubMed ID: 29630767
[TBL] [Abstract][Full Text] [Related]
14. Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: a risk-adapted therapeutic approach in Wilms' tumor.
Tournade MF; Com-Nougué C; Voûte PA; Lemerle J; de Kraker J; Delemarre JF; Burgers M; Habrand JL; Moorman CG; Bürger D
J Clin Oncol; 1993 Jun; 11(6):1014-23. PubMed ID: 8388918
[TBL] [Abstract][Full Text] [Related]
15. Blastemal predominant type Wilms tumor in Japan: Japan Children's Cancer Group.
Koshinaga T; Takimoto T; Okita H; Tanaka Y; Inoue E; Oue T; Nozaki M; Tsuchiya K; Haruta M; Kaneko Y; Fukuzawa M
Pediatr Int; 2019 Apr; 61(4):351-357. PubMed ID: 30786111
[TBL] [Abstract][Full Text] [Related]
16. [Treatment results in patients treated from 1980 to 2004 for Wilms' tumour in a single centre].
Malis J; Radvanská J; Slabý K; Eckschlager T; Procházka M; Malinová B; Pýcha K; Kodetová D; Radvanský J
Klin Onkol; 2010; 23(5):332-42. PubMed ID: 21061683
[TBL] [Abstract][Full Text] [Related]
17. Wilms tumor: five-year tumor-free survival on a modified SIOP protocol from an Indian university hospital.
Trehan A; Chowdhary SK; Marwaha RK
J Pediatr Hematol Oncol; 2012 Jan; 34(1):57-62. PubMed ID: 21423048
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of disease classified as stage III in Wilms tumor: a report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
Spreafico F; Gandola L; D'Angelo P; Terenziani M; Collini P; Bianchi M; Provenzi M; Indolfi P; Pession A; Nantron M; Di Cataldo A; Marchianò A; Catania S; Fossati Bellani F; Piva L;
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):348-54. PubMed ID: 21075548
[TBL] [Abstract][Full Text] [Related]
19. Challenges and outcome of Wilms' tumour management in a resource-constrained setting.
Wilde JC; Lameris W; van Hasselt EH; Molyneux EM; Heij HA; Borgstein EG
Afr J Paediatr Surg; 2010; 7(3):159-62. PubMed ID: 20859020
[TBL] [Abstract][Full Text] [Related]
20. Age is not a prognostic factor in children with Wilms tumor beyond stage I in Africa.
Aronson DC; Hadley GP
Pediatr Blood Cancer; 2014 Jun; 61(6):987-9. PubMed ID: 24453084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
